Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: TAK-788
Total 0 results
Nothing found
Sponsors and Collaborators
Medical School University of Zagreb
Tianjin Medical University
Etablissement Publique de Santé Mentale de la Réunion
Jadran Galenski laboratorij d.d.Rijeka
CK-CARE (Christine Kühne - Center for Allergy Research and Education)
Ministry of Tourism, Sport and the Arts, British Columbia
Diabetech
Pyrotech Therapeutics, Inc.
Marta Camats Terre
Centre de Pharmacologie Clinique, INSERM CIC 501
First Hospital Affiliated to Baotou Medical College, Baotou, China
St. Louis Children's Hospital
PharmTest s.r.o.
Uzès hospital
ViiV Healthcare Australia Pty. Ltd
Incept BioSystems, Inc.
Vaxxinity, Inc.
Institutos Nacionales de Salud, USA Instituto Alemán del Cáncer
MRC/UVRI & LSHTM Uganda Research Unit
Medtronic Poland Spółka z ograniczoną odpowiedzialnością
View Full List
Medical Conditions
Relapsed Malignant Solid Tumor
Neoplasms, Advanced Solid
Central Centrifugal Cicatricial Alopecia (CCCA)
Critical Illness Sepsis, Severe
Post-Cerebrovascular Accident (CVA) Hemiparesis
Repository Corticotropin Injection
Nonarthritic Hip Disease
Native and Valve in Valve Aortic Valve Failure
High Turnover Bone Disease
Vomit
Breast Cancer Treatment
Family Functioning
Human Papilloma Virus Infection
Fenofibrate
Vasomotor Symptoms Associated With Menopause
Well-trained Athletes
Hepatitis C, Treatment Naïve, Genotype 1 Patients
Pulpotomy of Young Permanent Molars
Oral Allergic Syndrome
Non-sedentary
View Full List
Drug Interventions
Experimental DW224aa
Olorofim
0.45% saline in 5% dextrose (intravenous)
Keytruda
Tamsulosin
ASP2151
Weak steroid (Flurolon, Allergan)
SPLA2 Inhibitor
Phenelzine Sulfate
Oxaliplatin
Carboplatin
Prazosin
RoActemra sc
Famciclovir
Sulfasalazine
Ropivacaine 0.2%
40 consecutive doses of SUF NT 15 mcg taken every 20 minutes
Durvalumab
SHR-1210
Lidocaine
View Full List
CROs by country
Contract Research Organizations in Bahamas
Contract Research Organizations in Belarus
Contract Research Organizations in Chile
Contract Research Organizations in Croatia
Contract Research Organizations in Finland
Contract Research Organizations in Ghana
Contract Research Organizations in Kenya
Contract Research Organizations in Kosovo
Contract Research Organizations in Morocco
Contract Research Organizations in Netherlands
Contract Research Organizations in Norway
Contract Research Organizations in Taiwan
Contract Research Organizations in Uzbekistan
CRO list by country
CROs in Zimbabwe
SGS
All CROs in Zimbabwe
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe